Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

631
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
631
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

315
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
315
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

484
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
484
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

546
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
546
Autoimmune Disorders01:29

Autoimmune Disorders

711
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
711
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

736
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
736

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility and signal quality of the Minder® implantable continuous EEG monitoring® system compared to 10-20 scalp electrodes over extended monitoring periods.

Epilepsia·2026
Same author

Is EEG useful in predicting neurotoxicity and outcomes related to chimeric antigen receptor (CAR) T-cell therapy?

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2026
Same author

Development of anti-LGI1 autoimmune encephalitis outcome rating score using the Rasch analysis.

Journal of neurology·2025
Same author

The UMPIRE study: A first-in-human multicenter trial of bilateral subscalp monitoring for epileptic seizure detection.

Epilepsia·2025
Same author

Seizures Associated with Autoimmune Disorders - Current Treatment Approaches.

Seminars in neurology·2025
Same author

Investigating the frequency of neural autoantibodies in refractory focal epilepsy.

Seizure·2025

Related Experiment Video

Updated: Sep 27, 2025

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
06:58

A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

Published on: July 12, 2021

5.1K

Autoimmune-Associated Seizures.

Lisa Gillinder, Jeffrey Britton

    Continuum (Minneapolis, Minn.)
    |April 8, 2022
    PubMed
    Summary
    This summary is machine-generated.

    Autoimmune seizures, often resistant to standard treatments, can be identified by specific seizure patterns and clinical features. Early diagnosis and immunotherapy are crucial for effective management of autoimmune epilepsy and encephalitis.

    More Related Videos

    Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
    07:01

    Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

    Published on: May 16, 2019

    9.2K
    Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
    09:57

    Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

    Published on: September 20, 2024

    2.8K

    Related Experiment Videos

    Last Updated: Sep 27, 2025

    A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
    06:58

    A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy

    Published on: July 12, 2021

    5.1K
    Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
    07:01

    Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

    Published on: May 16, 2019

    9.2K
    Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
    09:57

    Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

    Published on: September 20, 2024

    2.8K

    Area of Science:

    • Neurology
    • Immunology
    • Epilepsy Research

    Background:

    • Autoimmune seizures are an emerging clinical challenge.
    • These seizures are often refractory to conventional antiseizure medications.
    • Delayed diagnosis leads to missed immunotherapy opportunities.

    Purpose of the Study:

    • To detail seizure manifestations in autoimmune-associated epilepsy and encephalitis.
    • To clarify the diagnostic role of central nervous system autoantibodies.
    • To review patient selection for antibody testing and outline immunotherapy approaches.

    Main Methods:

    • Literature review of autoimmune seizure presentations.
    • Analysis of autoantibody specificity in neurological autoimmunity.
    • Evaluation of current diagnostic and therapeutic guidelines.

    Main Results:

    • Specific seizure characteristics (frequency, timing, duration, symptoms) aid in differentiating autoimmune seizures.
    • Various scoring systems can assist in identifying autoimmune epilepsy.
    • Central nervous system autoantibodies are key indicators of immune etiology.

    Conclusions:

    • Recognizing autoimmune seizure presentations is critical for timely diagnosis.
    • Autoimmune seizures often respond well to immunotherapy.
    • Further research into autoimmune seizure manifestations and treatments is ongoing.